Literature DB >> 12772856

Effect of ketoprofen, lidocaine local anesthesia, and combined xylazine and lidocaine caudal epidural anesthesia during castration of beef cattle on stress responses, immunity, growth, and behavior.

S T L Ting1, B Earley, J M L Hughes, M A Crowe.   

Abstract

To determine the effects of burdizzo castration alone or in combination with ketoprofen (K), local anesthesia (LA), or caudal epidural anesthesia (EPI) on plasma cortisol, acute-phase proteins, interferon-gamma production, growth, and behavior of beef cattle, 50 Holstein x Friesian bulls (13 mo old, 307 +/- 5.3 kg) were assigned to (n = 10/treatment): 1) control (handled; C); 2) burdizzo castration (B); 3) B following K (3 mg/ kg of BW i.v.; BK); 4) B following LA (8 mL into each testis and 3 mL s.c. along the line where the jaws of the burdizzo were applied with 2% lidocaine HCl; BLA); and 5) B following EPI (0.05 mg/kg of BW of xylazine HCl and 0.4 mg/kg of BW of lidocaine HCl as caudal epidural; BEPI). The area under the cortisol curve against time was lower (P < 0.05) in BK than in B, BLA, or BEPI animals. On d 1 after treatment, plasma haptoglobin concentrations were higher (P < 0.05) in B, BLA, and BEPI than in BK animals. On d 3, haptoglobin and plasma fibrinogen concentrations were higher (P < 0.05) in all castration groups than in C. On d 7, haptoglobin and fibrinogen concentrations remained higher (P < 0.05) in BLA than in B and C animals. On d 1, concanavalin A-induced interferon-gamma production was lower (P < 0.05) in B, BLA, and BEPI than in C, but there was no difference between BK and C animals. From d -1 to 35, ADG was lower (P < 0.05) in B, BLA, and BEPI animals, but not in BK compared with C animals. Overall, there was a higher (P < 0.05) incidence of combined abnormal postures in B than in C, BK and BEPI animals. Although the use of K and EPI decreased (P < 0.05) these postures compared with B alone or B with LA, there was no difference between the K and EPI treatment. In conclusion, burdizzo castration increased plasma cortisol and acute-phase proteins, and suppressed immune function and growth rates. Local anesthesia prolonged the increase in acute-phase proteins. Ketoprofen was more effective than LA or EPI in decreasing cortisol and partially reversed the reduction in ADG following castration. The use of K or EPI was more effective than LA in decreasing pain-associated behavioral responses observed during the first 6 h after treatment. Systemic analgesia with ketoprofen, a non-steroidal antiinflammatory drug, was more effective in reducing inflammatory responses associated with castration than LA or EPI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12772856     DOI: 10.2527/2003.8151281x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  12 in total

1.  Zinc injection as a novel castration method in beef bulls: effects on performance, behavior, and testosterone and haptoglobin concentration.

Authors:  Jase J Ball; Elizabeth B Kegley; Ty E Lawrence; Shelby L Roberts; Jeremy G Powell; John T Richeson
Journal:  J Anim Sci       Date:  2018-04-03       Impact factor: 3.159

2.  Effect of subcutaneous meloxicam on indicators of acute pain and distress after castration and branding in 2-mo-old beef calves1,2.

Authors:  Daniela M Meléndez; Sonia Marti; Ed A Pajor; Diego Moya; Désirée Gellatly; Eugene D Janzen; Karen S Schwartzkopf-Genswein
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

3.  The behavioral assessment and alleviation of pain associated with castration in beef calves treated with flunixin meglumine and caudal lidocaine epidural anesthesia with epinephrine.

Authors:  Jan M Currah; Steven H Hendrick; Joseph M Stookey
Journal:  Can Vet J       Date:  2009-04       Impact factor: 1.008

4.  Examination of the bovine leukocyte environment using immunogenetic biomarkers to assess immunocompetence following exposure to weaning stress.

Authors:  Aran O'Loughlin; Mark McGee; Sinéad M Waters; Sean Doyle; Bernadette Earley
Journal:  BMC Vet Res       Date:  2011-08-11       Impact factor: 2.741

5.  Objective Measures for the Assessment of Post-Operative Pain in Bos indicus Bull Calves Following Castration.

Authors:  Gabrielle C Musk; Stine Jacobsen; Timothy H Hyndman; Heidi S Lehmann; S Jonathon Tuke; Teresa Collins; Karina B Gleerup; Craig B Johnson; Michael Laurence
Journal:  Animals (Basel)       Date:  2017-09-28       Impact factor: 2.752

6.  Effect of meloxicam and lidocaine administered alone or in combination on indicators of pain and distress during and after knife castration in weaned beef calves.

Authors:  Daniela M Meléndez; Sonia Marti; Edmond A Pajor; Pritam K Sidhu; Désirée Gellatly; Diego Moya; Eugene D Janzen; Johann F Coetzee; Karen S Schwartzkopf-Genswein
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

7.  Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) on a request from the Commission related with the risks of poor welfare in intensive calf farming systems.

Authors: 
Journal:  EFSA J       Date:  2006-06-06

8.  Validation of the UNESP-Botucatu unidimensional composite pain scale for assessing postoperative pain in cattle.

Authors:  Flávia Augusta de Oliveira; Stelio Pacca Loureiro Luna; Jackson Barros do Amaral; Karoline Alves Rodrigues; Aline Cristina Sant'Anna; Milena Daolio; Juliana Tabarelli Brondani
Journal:  BMC Vet Res       Date:  2014-09-06       Impact factor: 2.741

9.  Effect of Ketoprofen on acute phase protein concentrations in goats undergoing castration.

Authors:  Umit Karademir; Ibrahim Akin; Hasan Erdogan; Kerem Ural; Gamze Sevri Ekren Asici
Journal:  BMC Vet Res       Date:  2016-06-23       Impact factor: 2.741

10.  Analgesic effects of intravenous flunixin and intrafunicular lidocaine or their combination for castration of lambs.

Authors:  Paola Straticò; Vincenzo Varasano; Riccardo Suriano; Massimo Mariscoli; Domenico Robbe; Melania Giammarco; Giorgio Vignola; Lucio Petrizzi
Journal:  Vet Rec Open       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.